Combination inactivated vaccine
This page covers all Combination inactivated vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Diphtheria toxin, tetanus toxin, Bordetella pertussis antigens (PT, FHA, PRN), poliovirus types 1, 2, and 3.
Targets
Marketed (2)
- DTacP-IPV combined vaccine (TETRAXIM™) · Sanofi · Immunology
- GamEvac-Combi (vaccine) · Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation · Immunology / Infectious Disease
GamEvac-Combi is a combination vaccine that stimulates immune responses against tick-borne encephalitis and Lyme disease through viral antigens.